Drug intelligence / Profile preview

sennosides + docusate sodium

Development stage
Unknown
Lead developer
SDA Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Senna Plus is an over-the-counter combination pharmaceutical product developed and marketed by SDA Laboratories for the treatment of occasional constipation. It contains two active small molecule ingredients: sennosides and docusate sodium. Sennosides are stimulant laxatives derived from the senna plant; they act as prodrugs that are hydrolyzed by colonic bacteria into active anthraquinone derivatives (rhein anthrones). These metabolites stimulate the myenteric plexus and irritate the colonic mucosa, leading to increased peristalsis and water secretion into the intestinal lumen. Docusate sodium is an anionic surfactant that functions as a stool softener by reducing the surface tension of the fecal mass, which allows water and lipids to penetrate and soften the stool. This dual-action mechanism provides both stimulatory effects on the bowel and softening of the stool to facilitate easier evacuation.

Brand names
Senna PlusSenna Plus 8.6mg
Other names
Senna-SSenna/Docusate SodiumSenna-Docusate
02

Targets

DNMT1 (DNA (cytosine-5)-methyltransferase 1)

Beyond the preview

Go deeper on sennosides + docusate sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sennosides + docusate sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call